Figure 2.

Change in mean systolic ambulatory blood pressure (A, C) and mean diastolic ambulatory blood pressure (B, D) with lumiracoxib and ibuprofen over the 24-h assessment periods (mmHg) at baseline and week 4 in patients with well-controlled hypertension on ARB monotherapy (A, B) or ACE monotherapy (C, D). ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BP, blood pressure; MDABP, mean diastolic ambulatory blood pressure; MSABP, mean systolic ambulatory blood pressure; od, once daily; tid, thrice daily